Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults-Reference-Cited by-同舟云学术

Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults

Published:2023-10 Issue:44 Volume:41 Page:6488-6501
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Nussbaum Jesse^ORCID,Cao Xin,Railkar Radha A.,Sachs Jeffrey R.,Spellman Daniel S.,Luk Julie,Shaw Christine A.^ORCID,Cejas Pedro J.,Citron Michael P.^ORCID,Al-Ibrahim Mohamed,Han David,Pagnussat Sandra,Stoch S. Aubrey,Lai Eseng^ORCID,Bett Andrew J.,Espeseth Amy S.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference59 articles.

1. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies;Anderson;J Infect Dis,1985

2. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins;Johnson;Proc Natl Acad Sci,1987

3. Severity of respiratory syncytial virus infection is related to virus strain;Walsh;J Infect Dis,1997

4. Risk of primary infection and reinfection with respiratory syncytial virus;Glezen;Am J Dis Child,1986

5. Natural reinfection of adults by respiratory syncytial virus. Possible relation to mild upper respiratory disease;Johnson;N Engl J Med,1962

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple Questions About Protection From Respiratory Syncytial Virus;Pediatric Infectious Disease Journal;2024-06-13

2. Efficacy of Respiratory Syncytial Virus Vaccination to Prevent Lower Respiratory Tract Illness in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Vaccines;2024-05-05

3. Correlating Stability-Indicating Biochemical and Biophysical Characteristics with In Vitro Cell Potency in mRNA LNP Vaccine;Vaccines;2024-02-07

4. Vaccination for Respiratory Syncytial Virus: A Narrative Review and Primer for Clinicians;Vaccines;2023-12-02